Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin in esophageal cancer treatment
IRCT2016070628814N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of enoxaparin in esophageal cancer and Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Mashhad University of Medical Sciences. Started Jul 2016; status: completed.
02
Drugs
enoxaparin
03
Conditions
esophageal cancerEsophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on IRCT2016070628814N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016070628814N1.